Condition

End-stage Liver Disease (ESLD) clinical trials and research

As of November 12, 2026, Find a Trial lists 3 End-stage Liver Disease (ESLD) clinical trials that are recruiting, at sites in 12 countries (most in Canada (1), Austria (1), Belgium (1)). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest End-stage Liver Disease (ESLD) clinical trials

StudyPhaseWhereStatusRegistered
Restrictive fluid strategy with phlebotomy during liver transplantation — Vancouver, British Columbia and 3 other locations Recruiting Jul 10, 2026
Reference framework for outcomes after machine-preserved liver transplantation in Europe — Innsbruck and 37 other locations Recruiting May 14, 2026
Tranexamic acid to reduce bleeding in adult liver transplant — Shanghai, Shanghai Municipality Recruiting Sep 5, 2025

All recruiting trials (3)

Related topics

Liver TransplantationAcute Liver FailureLiver CirrhosisLiver Transplantation (LT)Tranexamic Acid

Quick answers

How many End-stage Liver Disease (ESLD) clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 12 countries. The most sites are in Canada (1 trial), Austria (1 trial), Belgium (1 trial), France (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.